These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22971295)

  • 21. Epidemiology of diabetic kidney disease.
    Reutens AT
    Med Clin North Am; 2013 Jan; 97(1):1-18. PubMed ID: 23290726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy.
    Kimura S; Inoguchi T; Yokomizo H; Maeda Y; Sonoda N; Takayanagi R
    Diabetes Obes Metab; 2012 Jul; 14(7):666-9. PubMed ID: 22268518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T; Khanna A; Kimball K; Wesson DE
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
    Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of diabetic nephropathy.
    Wittmann I; Molnár GA; Degrell P; Wagner Z; Tamaskó M; Laczy B; Brasnyó P; Wagner L; Nagy J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephropathy in non-insulin-dependent (type-2) diabetes mellitus].
    Nagy J; Wittmann I
    Orv Hetil; 2000 Mar; 141(12):609-14. PubMed ID: 10769544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic nephropathy in insulin-dependent diabetes mellitus: pathogenesis and treatment strategies.
    Bilo HJ; Gans RO; Elving L; de Nobel E; Donker AJ
    Neth J Med; 1990 Feb; 36(1-2):74-85. PubMed ID: 2179753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G; Macia M; Ruggenenti P
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in diabetic nephropathy.
    Marshall SM
    Postgrad Med J; 2004 Nov; 80(949):624-33. PubMed ID: 15537844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
    Shestakova MV; Mukhin NA; Dedov II; Titov VN; Pomerantseva NV; Okunev DIu; Lipitskaia IIa
    Ter Arkh; 1991; 63(6):50-5. PubMed ID: 1948747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Bakris GL; Agarwal R; Anker SD; Pitt B; Ruilope LM; Nowack C; Kolkhof P; Ferreira AC; Schloemer P; Filippatos G; ;
    Am J Nephrol; 2019; 50(5):333-344. PubMed ID: 31655812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy in patients with type 1 diabetes mellitus.
    Russell TA
    Nephrol Nurs J; 2006; 33(1):15-28; quiz 29-30. PubMed ID: 16538925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
    Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
    Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What is new in the treatment of diabetes?--The importance of nephro- and cardioprotective management].
    Czekalski S
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():65-9. PubMed ID: 15669203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 39. [DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].
    Kos I; Prkačin I
    Acta Med Croatica; 2014 Dec; 68(4-5):375-81. PubMed ID: 26285470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.
    Phisitkul K; Hegazy K; Chuahirun T; Hudson C; Simoni J; Rajab H; Wesson DE
    Am J Med Sci; 2008 Apr; 335(4):284-91. PubMed ID: 18414067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.